These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 6161971)
1. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. Hintner H; Stingl G; Schuler G; Fritsch P; Stanley J; Katz S; Wolff K J Invest Dermatol; 1981 Feb; 76(2):113-8. PubMed ID: 6161971 [TBL] [Abstract][Full Text] [Related]
2. [Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment]. Hintner H; Schuler G; Fritsch P Hautarzt; 1982 Jun; 33(6):310-4. PubMed ID: 6179897 [TBL] [Abstract][Full Text] [Related]
3. Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae. Klein GF; Hintner H; Schuler G; Fritsch P Br J Dermatol; 1983 Nov; 109(5):499-508. PubMed ID: 6357262 [TBL] [Abstract][Full Text] [Related]
4. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin. Fine JD J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876 [TBL] [Abstract][Full Text] [Related]
5. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371 [TBL] [Abstract][Full Text] [Related]
6. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). Briggaman RA; Gammon WR; Woodley DT J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982 [TBL] [Abstract][Full Text] [Related]
7. Immunohistological localization of three basement membrane components in various forms of epidermolysis bullosa. Kero M; Peltonen L; Foidart JM; Savolainen ER J Cutan Pathol; 1982 Oct; 9(5):316-28. PubMed ID: 7142519 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa. Petronius D; Bergman R; Ben Izhak O; Leiba R; Sprecher E Am J Dermatopathol; 2003 Jun; 25(3):198-203. PubMed ID: 12775981 [TBL] [Abstract][Full Text] [Related]
9. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa. Rao R; Mellerio J; Bhogal BS; Groves R Indian J Dermatol Venereol Leprol; 2012; 78(6):692-7. PubMed ID: 23075637 [TBL] [Abstract][Full Text] [Related]
10. [Epidermolysis bullosa acquisita--manifestations in otorhinolaryngology]. Schenk P; Konrad K Laryngol Rhinol Otol (Stuttg); 1983 Oct; 62(10):456-62. PubMed ID: 6358736 [TBL] [Abstract][Full Text] [Related]
11. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa. Fine JD; Gay S Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588 [TBL] [Abstract][Full Text] [Related]
12. KF-1 monoclonal antibody defines a specific basement membrane antigen defect in dystrophic forms of epidermolysis bullosa. Fine JD; Breathnach SM; Hintner H; Katz SI J Invest Dermatol; 1984 Jan; 82(1):35-8. PubMed ID: 6361168 [TBL] [Abstract][Full Text] [Related]